Andre CHOLLET
9Patents
3h-index
1Co-inventors
39Inventor score
Filing activity: Sep 8, 2014 → Mar 26, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9670155B2 | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists | Chemistry; Metallurgy | 7 | Active |
| US9962367B2 | Oral formulations of pyrrolidine derivatives | Human Necessities | 4 | Active |
| US10047048B2 | Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists | Chemistry; Metallurgy | 3 | Active |
| US10478420B2 | Oral formulations of pyrrolidine derivatives | Human Necessities | 2 | Active |
| US9718772B2 | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same | Chemistry; Metallurgy | 2 | Active |
| US10604482B2 | Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists | Chemistry; Metallurgy | 2 | Active |
| US11419851B2 | Oral formulations of pyrrolidine derivatives | Human Necessities | 0 | Active |
| US11312683B2 | Pyrrolidine derivatives as oxytocin/vasopressin via receptors antagonists | Chemistry; Metallurgy | 0 | Active |
| US10752583B2 | Crystalline (3Z,5S)-5-(hydroxymethyl)-1-[(2′-methyl-1,1′-biphenyl-4-yl)carbonyl]pyrrolidin-3-one O-methyloxime, and methods of using the same | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.